Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 9DM72 | — |
Shingrix late second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who did not receive Herpes zoster (Shingrix) (batch number 9DM72, expiry date 28-JAN-2023) for prophylaxis. Previously administered products included Shingrix (received first dose on 21-SEP-2021). On an unknown date, the patient did not receive the 2nd dose of Shingrix. The patient had incomplete course of vaccination (Verbatim: Shingrix late second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 30-SEP-2025 The reporter reported that patient got Shingrix first dose on 21st September 2021 with batch lot 9DM72 and expiry on 28th January 2023. Till the time of reporting, the patients did not receive the second dose of Shingrix, which led to incomplete course of vaccination. This case US2025125451 was reported by same reporter.; Sender's Comments: US-GSK-US2025125451:first patient case